Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Dell Technologies Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Boplicity who wrote (154063)	2/17/2000 5:11:00 PM
From: stockman_scott	Read Replies (1) \| Respond to of 176387

~OT~...<<Thursday February 17, 4:53 pm Eastern Time Alert: Immunex Trades Up to 210-33/64 After Hours Versus 194-3/16 Close (NasdaqNM:IMNX, health)>> Greg: I used to own IMNX when it was still under $100/share....sometimes we sell some real winners too soon <G>....BTW, check out the IMNX chart for the last year. It's actually a bluechip biotech firm in overdrive (makes a drug company stock look kinda sick)....The other Seattle firm that really outperformed the Nasdaq in the last year was InfoSpace (INSP) -- wow, what a run...I used to own that one too (got in right after the IPO and sold after it flattened out)....Hmmmm....I often can select GREAT stocks to invest in. The challenge is holding the real winners and letting them run. What criteria do you use to decide when to sell a stock...?? Best Regards, Scott